ISAKOS: 2023 Congress in Boston, MA USA

ISAKOS 2023 Congress Abstract Author

 

Sjoerd A.S. Stufkens, MD, PhD

Amsterdam NETHERLANDS

Sun 06/18
10:25 - 10:30 		Room 311 Scientific Paper Block: Foot & Ankle
Paper
Arthroscopic Bone Marrow Stimulation for Osteochondral Lesions of the Tibial Plafond Yields Satisfactory Outcomes in 77% of Patients
Author
Sun 06/18
16:05 - 16:10 		Room 210 Scientific Paper Block: Foot & Ankle
Paper
Satisfactory Patient Reported Outcomes at 15-Years Follow-Up Of Arthroscopic Bone Marrow Stimulation for Osteochondral Lesions of the Talus
Author
Sun 06/18
16:10 - 16:15 		Room 210 Scientific Paper Block: Foot & Ankle
Paper
Talar Osteoperiostic Grafting From The Iliac Crest (Topic): Return To Sports Outcomes Of A Novel Press-Fit Surgical Treatment For Large Talar Osteochondral Lesions
Author
Sun 06/18
16:15 - 16:20 		Room 210 Scientific Paper Block: Foot & Ankle
Paper
Second-Look Arthroscopy After Surgery For Osteochondral Lesions of the Talus: A Systematic Review and Meta-Analysis
Author
Sun 06/18
16:20 - 16:25 		Room 210 Scientific Paper Block: Foot & Ankle
Paper
Talar Osteoperiostic Grafting From The Iliac Crest (Topic): 2-Year Results Of A Novel Press-Fit Surgical Treatment For Large Talar Osteochondral Lesions
Author
Sun 06/18
16:30 - 16:35 		Room 210 Scientific Paper Block: Foot & Ankle
Paper
75% Survival Rate 15-Years After Arthroscopic Bone Marrow Stimulation For Osteochondral Lesions Of The Talus
Author
Sun 06/18
16:40 - 16:45 		Room 210 Scientific Paper Block: Foot & Ankle
Paper
Sustained Clinical Success at 7 Years Follow-Up After Arthroscopic Lift-Drill-Fill-Fix (LDFF) Of Primary Osteochondral Lesions of the Talus
Author
ePosters
Ankle/Foot/Calf
E-Poster
4% Annual Revision Rate in Ankle Distraction for Ankle Osteoarthritis: A Systematic Review and Meta-Analysis
Author
ePosters
Ankle/Foot/Calf
E-Poster
The Frequency and Severity of Complications in Surgical Treatment of Osteochondral Lesions of the Talus: A Systematic Review and Meta-Analysis of 6,962 Lesions
Author

Disclosures

No Financial Conflicts to Disclose
All relevant financial disclosures have been mitigated.

View All Global Link Presentations

↑